Ayer, MA, United States of America

Anthony Joseph Cura

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anthony Joseph Cura: Innovator in Protein Production

Introduction

Anthony Joseph Cura is a notable inventor based in Ayer, Massachusetts. He has made significant contributions to the field of protein production through his innovative research and patent work. His expertise lies in the assessment of disulfide bond reduction in proteins, which is crucial for various biotechnological applications.

Latest Patents

Cura holds a patent titled "Metabolic enzyme activity and disulfide bond reduction during protein production." This patent focuses on the use of host cell protein biomarkers to evaluate disulfide bond reduction in protein compositions. The methods described in the patent allow for predicting the occurrence of disulfide bond reduction or low molecular weight protein species by measuring the expression or activity level of specific host cell proteins. This innovation enhances the production and isolation processes of proteins of interest.

Career Highlights

Cura is currently employed at Bristol-Myers Squibb Company, where he applies his knowledge and skills in protein production. His work contributes to the development of therapeutic proteins, which are essential in modern medicine. With a patent portfolio that includes one patent, he continues to push the boundaries of biotechnological research.

Collaborations

Cura has collaborated with esteemed colleagues such as Xuankuo Xu and Zhengjian Li. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in protein production.

Conclusion

Anthony Joseph Cura is a prominent figure in the field of protein production, with a focus on disulfide bond reduction. His contributions through patents and collaborations highlight his commitment to advancing biotechnological research. His work at Bristol-Myers Squibb Company continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…